Madrigal Pharmaceuticals
MDGL
#1789
Rank
โ‚ฌ10.10 B
Marketcap
438,20ย โ‚ฌ
Share price
-0.71%
Change (1 day)
61.95%
Change (1 year)

EPS for Madrigal Pharmaceuticals (MDGL)

EPS in 2025 (TTM): -11,20ย โ‚ฌ

According to Madrigal Pharmaceuticals 's latest financial reports the company's current EPS (TTM) is -10,98ย โ‚ฌ. an increase over its 2024 EPS that were of -18,86ย โ‚ฌ.

EPS history for Madrigal Pharmaceuticals from 2016 to 2025

Annual EPS

Year EPS Change
2025-10,98ย โ‚ฌ-41.79%
2024-18,86ย โ‚ฌ
2022-14,70ย โ‚ฌ17.93%
2021-12,46ย โ‚ฌ11.61%
2020-11,17ย โ‚ฌ140.18%
2019-4,65ย โ‚ฌ146.61%
2018-1,89ย โ‚ฌ-12.99%
2017-2,17ย โ‚ฌ-91.03%
2016-24,15ย โ‚ฌ

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
OPKO Health
OPK
-0,20ย โ‚ฌ-98.14%๐Ÿ‡บ๐Ÿ‡ธ USA
Onconova Therapeutics
ONTX
-0,81ย โ‚ฌ-92.62%๐Ÿ‡บ๐Ÿ‡ธ USA